Dynatrace
DT
59.81
-1.24
-2.03%
Dynatrace
US · DT
#1052 by market cap
Listed 2019
59.81
-1.24
-2.03%
Live - 5344 symbols - heartbeat 117s ago
· 2026-10-08 06:40
Pre-market
60.59
+1.30%
After-hours
60.14
+0.55%
Overnight
59.45
-0.60%
- Market cap
- 17.29B
- P/E (TTM)i
- 119.62
- P/Bi
- 7.05
- EPSi
- 0.54
- Div yieldi
- 0.00%
- 52W posi
- 94%
Reader sentiment
Are you bullish or bearish on DT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.69, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +18.82% YoY
Margins
- Gross margin
- 81.56%
- Operating margin
- 13.08%
- Net margin
- 8.06%
Key ratios & quality
- PEG ratioi
- 8.17
- Altman Z-Scorei
- 6.69
PEG uses trailing P/E against the 3-year net income growth rate (14.64%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 430.97M | 545.80M | 703.51M | 929.45M | 1.16B | 1.43B | 1.70B | 2.02B |
| Gross profit | 324.17M | 416.87M | 575.80M | 756.57M | 935.64M | 1.16B | 1.38B | 1.65B |
| Selling & admin expenses | 270.66M | 428.16M | 337.71M | 488.76M | 598.19M | 708.65M | 800.95M | 907.90M |
| Research & development | 76.76M | 119.28M | 111.42M | 156.34M | 218.35M | 304.74M | 384.57M | 474.31M |
| Operating profit | -70.94M | -170.85M | 91.94M | 81.31M | 92.81M | 128.40M | 179.43M | 263.91M |
| Pretax profit | -139.91M | -218.53M | 77.85M | 71.66M | 89.97M | 154.92M | 223.43M | 299.76M |
| Tax | -23.72M | 195.28M | 2.14M | 19.21M | -17.99M | 283.00K | -260.26M | 137.09M |
| Net profit | -116.19M | -413.82M | 75.71M | 52.45M | 107.96M | 154.63M | 483.68M | 162.67M |
| Basic EPS | 0 | -2 | 0 | 0 | 0 | 1 | 2 | 1 |
| Diluted EPS | -0.42 | -1.56 | 0.26 | 0.18 | 0.37 | 0.52 | 1.59 | 0.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 445.17M | 477.35M | 493.85M | 515.47M | 531.72M | 554.55M |
| Gross profit | 360.07M | 392.14M | 404.09M | 419.64M | 430.32M | 451.10M |
| Selling & admin expenses | 213.86M | 221.62M | 216.11M | 226.32M | 243.86M | 243.37M |
| Research & development | 103.29M | 108.17M | 114.99M | 120.57M | 130.58M | 135.99M |
| Operating profit | 42.91M | 62.34M | 72.97M | 72.74M | 55.87M | 71.48M |
| Pretax profit | 55.70M | 81.39M | 87.11M | 84.45M | 46.82M | 80.80M |
| Tax | 16.40M | 33.44M | 29.86M | 44.40M | 29.40M | 44.15M |
| Net profit | 39.30M | 47.96M | 57.24M | 40.06M | 17.42M | 36.65M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.13 | 0.16 | 0.19 | 0.13 | 0.06 | 0.12 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 213.22M | 487.78M | 680.28M | 948.42M | 1.12B | 1.61B | 1.93B | 2.12B |
| Cash & ST investments | 51.31M | 213.17M | 324.96M | 462.97M | 555.35M | 836.87M | 1.11B | 1.17B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.81B | 2.05B | 2.26B | 2.54B | 2.77B | 3.41B | 4.14B | 4.42B |
| Total current liabilities | 950.90M | 490.18M | 647.91M | 865.60M | 1.04B | 1.26B | 1.38B | 1.57B |
| Short-term debt | 606.65M | -- | 9.49M | 12.77M | 15.65M | 15.51M | 13.98M | 22.59M |
| Long-term debt | 1.01B | 509.99M | 391.91M | 273.92M | -- | -- | -- | -- |
| Total liabilities | 2,201,624,000.00 | 1,081,173,000.00 | 1,142,617,000.00 | 1,236,864,000.00 | 1,160,478,000.00 | 1,394,289,000.00 | 1,518,530,000.00 | 1,804,335,000.00 |
| Total equity | -390.26M | 965.70M | 1.11B | 1.30B | 1.60B | 2.02B | 2.62B | 2.61B |
| Retained earnings | -176.00M | -589.82M | -513.80M | -461.35M | -353.39M | -198.76M | 284.93M | 447.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.93B | 1.85B | 1.84B | 1.87B | 2.12B | 1.72B |
| Cash & ST investments | 1.11B | 1.35B | 1.31B | 1.19B | 1.17B | 1.11B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.14B | 4.08B | 4.08B | 4.10B | 4.42B | 4.11B |
| Total current liabilities | 1.38B | 1.23B | 1.16B | 1.19B | 1.57B | 1.43B |
| Short-term debt | 13.98M | 15.32M | 16.98M | 17.54M | 22.59M | 23.06M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,518,530,000.00 | 1,382,649,000.00 | 1,303,139,000.00 | 1,351,581,000.00 | 1,804,335,000.00 | 1,658,741,000.00 |
| Total equity | 2.62B | 2.70B | 2.78B | 2.75B | 2.61B | 2.45B |
| Retained earnings | 284.93M | 332.88M | 390.13M | 430.18M | 447.60M | 484.25M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 147.14M | -142.46M | 220.44M | 250.92M | 354.89M | 378.11M | 459.42M | 561.85M |
| Depreciation & amortization | 80.11M | 66.32M | 60.96M | 56.88M | 54.61M | 54.94M | 48.10M | 24.06M |
| Free cash flow | 137.89M | -163.07M | 206.56M | 233.22M | 333.35M | 346.38M | 430.62M | 529.48M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -649.00K | 590.14M | -49.00K | -66.00K | -15.00K | 0 | -172.62M | -478.71M |
| Ending cash balance | 51.31M | 213.17M | 324.96M | 462.97M | 555.35M | 778.98M | 1.02B | 1.10B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 162.79M | 269.69M | 32.02M | 33.78M | 226.36M | 306.24M |
| Depreciation & amortization | 6.65M | 6.46M | 5.70M | 5.73M | 6.16M | 7.65M |
| Free cash flow | 145.53M | 262.02M | 27.83M | 27.23M | 212.40M | 303.09M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -42.52M | -45.03M | -50.00M | -160.00M | -223.68M | -275.48M |
| Ending cash balance | 1.02B | 1.25B | 1.23B | 1.09B | 1.10B | 1.06B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -146.36 | 7.30 | 4.34 | 7.42 | 8.54 | 20.86 | 6.22 |
| ROA %i | -6.26 | -21.70 | 3.52 | 2.19 | 4.07 | 5.01 | 12.81 | 3.80 |
| ROIC %i | -- | -36.78 | 5.90 | 3.75 | 6.65 | 8.21 | 20.23 | 5.95 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -23.25 | 9.69 | 9.48 |
| EBIT margin %i | -16.26 | -31.72 | 13.09 | 8.81 | 8.06 | 8.98 | 10.56 | 13.08 |
| FCF / sales %i | 32.00 | -- | 29.36 | 25.09 | 28.77 | 24.21 | 25.35 | 26.23 |
| Current ratioi | 0.22 | 1.00 | 1.05 | 1.10 | 1.08 | 1.28 | 1.40 | 1.35 |
| Quick ratioi | 0.18 | 0.89 | 0.94 | 0.99 | 0.97 | 1.15 | 1.27 | 1.22 |
| Debt / assetsi | 89.35 | 24.92 | 19.48 | 13.33 | 2.72 | 2.04 | 1.82 | 3.72 |
| LT debt / equityi | -- | 52.81 | 38.62 | 24.99 | 3.71 | 2.68 | 2.34 | 5.43 |
| Interest coveragei | -1.00 | -3.81 | 6.48 | 8.03 | 27.39 | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | 10.33 | 20.91 | 29.20 | 28.52 | 26.69 | 22.26 | 20.33 |
| Net income CAGR (3Y) %i | -- | -- | 101.74 | -- | -- | 26.87 | 109.70 | 14.64 |
| FCF CAGR (3Y) %i | -- | -- | 25.86 | 19.15 | -- | 18.81 | 22.68 | 16.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 20.86 | 20.69 | 20.57 | 6.96 | 6.22 | 5.88 |
| ROA %i | 12.81 | 13.44 | 13.66 | 4.71 | 3.80 | 3.70 |
| ROIC %i | 20.23 | 19.98 | 19.89 | 6.76 | 5.95 | 5.61 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.56 | 11.24 | 12.18 | 12.99 | 13.08 | 13.03 |
| FCF / sales %i | 25.35 | 26.18 | 25.53 | 23.95 | 26.23 | 27.23 |
| Current ratioi | 1.40 | 1.50 | 1.59 | 1.56 | 1.35 | 1.21 |
| Quick ratioi | 1.27 | 1.33 | 1.41 | 1.39 | 1.22 | 1.04 |
| Debt / assetsi | 1.82 | 2.15 | 2.13 | 2.09 | 3.72 | 3.88 |
| LT debt / equityi | 2.34 | 2.68 | 2.51 | 2.48 | 5.43 | 5.56 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 06:40:48 · For reference only, not investment advice and not tailored to your situation.